FDA Approves Ampyra Despite Slight Responder Rate and Seizure Risk

FDA approved Ampyra extended release tablets with the novel indication of improvement in walking ability in adults with multiple sclerosis.

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet